A study published in Brazil considered that the drug Hydroxychloroquine is ineffective in the face of "Covid-19", even though the Brazilian President, Jair Bolsonaro, who is infected with the virus, is publicly promoting it.
The clinical trial was conducted in 55 hospitals in Brazil, and the results were published by the New England Journal of Medicine. Its aim was to find out if this drug, which provoked controversy, could, if taken with the antibiotic azithromycin, improve the condition of patients with a slight or moderate incidence of the "Covid-19" epidemic.
In the face of the pandemic, the Bolsonaro government has recommended since last May the use of hydroxychloroquine or anti-malarial chloroquine in conjunction with azetromycin.
The far-right president, who announced his HIV infection on July 7, has confirmed several times that his health has improved thanks to hydroxychloroquine. Sunday carried a box of this controversial drug, which was also promoted by US President Donald Trump.
However, several randomized trials have shown that it is ineffective and may have harmful side effects. The Brazilian study, conducted by a group of researchers and doctors under the so-called «Covid Coalition-19 Brazil», concluded the same result.
The study was conducted on 667 patients and concluded that those treated with hydroxychloroquine were more likely to have heart and liver problems.